These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 12667900)
41. Differential effects of chronic amphetamine and baclofen administration on cAMP levels and phosphorylation of CREB in distinct brain regions of wild type and monoamine oxidase B-deficient mice. Yin HS; Chen K; Kalpana S; Shih JC Synapse; 2006 Dec; 60(8):573-84. PubMed ID: 16983645 [TBL] [Abstract][Full Text] [Related]
42. Evaluation of unconditioned novelty-seeking and d-amphetamine-conditioned motivation in mice. Laviola G; Adriani W Pharmacol Biochem Behav; 1998 Apr; 59(4):1011-20. PubMed ID: 9586862 [TBL] [Abstract][Full Text] [Related]
43. Stress and withdrawal from d-amphetamine alter 5-HT2A receptor mRNA expression in the prefrontal cortex. Murray RC; Hebbard JC; Logan AS; Vanchipurakel GA; Gilbert YE; Horner KA Neurosci Lett; 2014 Jan; 559():44-9. PubMed ID: 24287377 [TBL] [Abstract][Full Text] [Related]
44. Parenterally administered 3-nitropropionic acid and amphetamine can combine to produce damage to terminals and cell bodies in the striatum. Bowyer JF; Clausing P; Schmued L; Davies DL; Binienda Z; Newport GD; Scallet AC; Slikker W Brain Res; 1996 Mar; 712(2):221-9. PubMed ID: 8814896 [TBL] [Abstract][Full Text] [Related]
45. Alpha2A-adrenoceptors are important modulators of the effects of D-amphetamine on startle reactivity and brain monoamines. Lähdesmäki J; Sallinen J; MacDonald E; Scheinin M Neuropsychopharmacology; 2004 Jul; 29(7):1282-93. PubMed ID: 15039766 [TBL] [Abstract][Full Text] [Related]
46. Behavioural consequences of withdrawal from three different administration schedules of amphetamine. Russig H; Murphy CA; Feldon J Behav Brain Res; 2005 Nov; 165(1):26-35. PubMed ID: 16157394 [TBL] [Abstract][Full Text] [Related]
47. Influence of lifelong dietary fats on the brain fatty acids and amphetamine-induced behavioral responses in adult rat. Trevizol F; Roversi K; Dias VT; Roversi K; Pase CS; Barcelos RC; Benvegnu DM; Kuhn FT; Dolci GS; Ross DH; Veit JC; Piccolo J; Emanuelli T; Bürger ME Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():215-22. PubMed ID: 23791617 [TBL] [Abstract][Full Text] [Related]
48. Characterization of pharmacological and wake-promoting properties of the dopaminergic stimulant sydnocarb in rats. Gruner JA; Mathiasen JR; Flood DG; Gasior M J Pharmacol Exp Ther; 2011 May; 337(2):380-90. PubMed ID: 21300706 [TBL] [Abstract][Full Text] [Related]
50. Effects of amphetamine on locomotor activity in adult and juvenile alcohol-preferring and -nonpreferring rats. McKinzie DL; McBride WJ; Murphy JM; Lumeng L; Li TK Pharmacol Biochem Behav; 2002; 71(1-2):29-36. PubMed ID: 11812505 [TBL] [Abstract][Full Text] [Related]
51. Sex differences and estrous cycle variations in amphetamine-elicited rotational behavior. Becker JB; Robinson TE; Lorenz KA Eur J Pharmacol; 1982 May; 80(1):65-72. PubMed ID: 7201404 [TBL] [Abstract][Full Text] [Related]
52. Effects of single and group housing conditions and alterations in social and physical contexts on amphetamine-induced behavioral sensitization in rats. Wang YC; Wang CC; Lee CC; Huang AC Neurosci Lett; 2010 Dec; 486(1):34-7. PubMed ID: 20851163 [TBL] [Abstract][Full Text] [Related]
53. D1 receptor-mediated inhibition of medial prefrontal cortex neurons is disrupted in adult rats exposed to amphetamine in adolescence. Kang S; Paul K; Hankosky ER; Cox CL; Gulley JM Neuroscience; 2016 Jun; 324():40-9. PubMed ID: 26946269 [TBL] [Abstract][Full Text] [Related]
56. Changes in the performance of schedule-induced polydipsia (SIP) in rats after arecoline and amphetamine treatments. Shen TF; Wang HC; Wan FJ; Tung CS Proc Natl Sci Counc Repub China B; 2001 Oct; 25(4):214-22. PubMed ID: 11699569 [TBL] [Abstract][Full Text] [Related]
57. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats. Shoblock JR; Sullivan EB; Maisonneuve IM; Glick SD Psychopharmacology (Berl); 2003 Feb; 165(4):359-69. PubMed ID: 12491026 [TBL] [Abstract][Full Text] [Related]
58. Paradoxical effects of D-amphetamine in infant and adolescent mice: role of gender and environmental risk factors. Cirulli F; Laviola G Neurosci Biobehav Rev; 2000 Jan; 24(1):73-84. PubMed ID: 10654663 [TBL] [Abstract][Full Text] [Related]
59. Increased sensitivity in dopamine D(2)-like brain receptors from 2,4-dichlorophenoxyacetic acid (2,4-D)-exposed and amphetamine-challenged rats. Bortolozzi A; Duffard R; Antonelli M; Evangelista de Duffard AM Ann N Y Acad Sci; 2002 Jun; 965():314-23. PubMed ID: 12105107 [TBL] [Abstract][Full Text] [Related]